NYSE · Analyst Forecast

Quest Diagnostics Incorporated (DGX) Stock Forecast & Price Target

$256.75 NYSE: DGX Market Cap $28.25B

Price as of Nov 17, 2026 (intraday, delayed) · Analyst estimates retrieved Nov 12, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Quest Diagnostics Incorporated (DGX), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Quest Diagnostics Incorporated, analysts forecast revenue rising from $10.98B in 2025 to $11.56B in 2030; the average estimate for 2030 earnings per share is $14.82; with published estimates ranging from $14.65 to $15.00; 13 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$256.75
Consensus targetThe average of the price targets analysts have published.$256.17
Median targetThe middle target, less affected by a single outlier.$260.00
Highest targetThe most optimistic published target.$262.00
Lowest targetThe most pessimistic published target.$245.00
Difference from priceHow far the consensus target sits from today’s price.-0.2%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$10.90B$10.98B$11.01B13
2026$11.99B$12.08B$12.11B13
2027$12.55B$12.63B$12.66B13
2028$12.87B$13.16B$13.42B11
2029$13.80B$13.92B$14.05B5
2030$11.46B$11.56B$11.67B5

Earnings per share forecast

YearLowAverageHighAnalysts
2025$9.77$9.81$9.8413
2026$11.19$11.32$11.3513
2027$11.71$11.98$12.3513
2028$12.17$13.06$14.2211
2029$14.48$14.64$14.825
2030$14.65$14.82$15.005

Quest Diagnostics Incorporated (DGX) forecast — frequently asked questions

What is the analyst price target for Quest Diagnostics Incorporated?

Analysts covering Quest Diagnostics Incorporated (DGX) have a consensus price target of $256.17, 0.2% below the current price of $256.75. Published targets range from $245.00 to $262.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Quest Diagnostics Incorporated's earnings?

The average analyst estimate for Quest Diagnostics Incorporated (DGX) earnings per share in 2030 is 14.82, with individual estimates between 14.65 and 15.00.

How much revenue is Quest Diagnostics Incorporated expected to make?

Analysts forecast Quest Diagnostics Incorporated (DGX) revenue of $11.56B in 2030, based on 5 published estimates.

How many analysts cover DGX?

13 analysts contribute estimates for Quest Diagnostics Incorporated (DGX). Thin coverage makes an average less reliable.

Analyst forecasts for other Medical - Diagnostics & Research stocks

TMO forecastDHR forecastIDXX forecastA forecastWAT forecastIQV forecastNTRA forecastMTD forecastILMN forecastLH forecastAll Medical - Diagnostics & Research stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.